frequencies – Communicable Diseases Research

Audiological profile of adult Long COVID patients

Article

Published on 2022-09-012022-11-16
Journal: American journal of otolaryngology [Category] SARS, 치료기술,

Epidemiological Comparison of Four COVID-19 Waves in the Democratic Republic of the Congo, March 2020-January 2022

Article

Published on 2022-09-012022-11-16
Journal: Journal of Epidemiology and Global Health [Category] SARS, 변종,

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study

중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 특이적 T 세포 및 항체, 코로나바이러스 질병 2019(COVID-19) 보호: 전향적 연구

Article

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, 치료법,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus analyzed antibody Antibody Response Antibody responses CD4+ CD8+ T cell CD8+ T cells clinical comparable coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 correlated COVID-19 demonstrated ELISPOT enzyme enzyme-linked immunosorbent evaluated flow cytometry followed by fraction Fractions frequencies Frequency healthcare highest IFN-γ IgG immune immune response Immunoglobulin Immunoglobulin G immunoglobulin M individual Infection interferon gamma interleukin interleukin 2 Kaplan-Meier estimator membrane nucleocapsid pandemic positive Probability Prospective PROTECT protective effect question Registration respiratory response SARS-CoV-2 SARS-COV-2 infection Spike protein Spike proteins staining T cell T cells T-cell T-cell and antibody responses T-cell Response T-cell responses the SARS-CoV-2 virus virus-specific antibodies Virus-specific IgG were infected with infection
[DOI] 10.1093/cid/ciac278 PMC 바로가기 [Article Type] Article

IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi

Karachi의 두 시점에서 무증상 헌혈자의 SARS-CoV-2에 대한 IgG 항체

Article

Published on 2022-08-242022-09-11
Journal: PLoS ONE [Category] SARS, 진단, 치료기술,

[키워드] 95% CI ABO age antibody Antigen Asymptomatic blood donor Blood donors Blood Group Blood groups Cohort COVID-19 COVID-19 infections Donor donors enrolled Enrollment exposure to frequencies Frequency group groups healthy healthy blood donor IgG IgG antibodies IgG antibody IgG response IgG responses incidence of COVID-19 individual individuals Infection Karachi male material no significant difference not differ pandemic protective immunity Proteins provide RBD reactivity Receptor binding domain reported SARS-CoV-2 SARS-CoV-2 PCR testing seropositive Seropositivity Seroprevalence significant difference spike subject Symptom university were measured
[DOI] 10.1371/journal.pone.0271259 PMC 바로가기 [Article Type] Article

Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination

SARS-CoV-2 비활성화 백신 접종 후 장기간 회복 중인 COVID-19 개인의 강력한 체액 및 세포 면역 반응

Article

Published on 2022-08-012022-09-11
Journal: Frontiers in Immunology [Category] SARS, 변종, 진단,

[키워드] addition anti-S Antigen antigen-specific T cell Antigen-specific T cells B cell booster caused CD4 Cellular immune response characterized convalescent COVID-19 death demonstrated Efficacy exhibited frequencies Frequency healthy healthy individual healthy individuals Hospitalization humoral IFN-γ IgG IL-2 immune immune responses inactivated Inactivated vaccine individual infected patient Infection long-term convalescent. NAbs Neutralizing antibodies neutralizing antibody neutralizing capacity RBD IgG RBD-specific IgG recipients recovered patient recovered patients robust SARS-CoV-2 SARS-CoV-2 inactivated vaccine SARS-CoV-2 RBD SARS-CoV-2 vaccine severe disease significantly significantly higher significantly increased single dose subject T cell T cell response T cell responses T cells the vaccine TNF-α utility vaccination Vaccine vaccine-induced immune response variants variants of concern VoC VOCs wild type
[DOI] 10.3389/fimmu.2022.966098 PMC 바로가기 [Article Type] Article

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials

동종 또는 이종 체계에서 항 SARS CoV-2 백신 SOBERANA 02의 안전성 및 면역원성: 공개 라벨 임상 1상 및 2a상 임상 시험

Clinical Trial

Published on 2022-07-292022-09-11
Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단,

[키워드] adaptive adverse event Anti-RBD IgG Antigen clinical trial clinical trials conjugate Conjugate vaccine COVID-19 COVID-19 vaccine D614G delta variant dose doses elicited ELISA evaluate evaluated frequencies Frequency hACE2 Heterologous heterologous immunization Heterologous immunization scheme homologous homologous or heterologous IgG IgG ELISA IIa immune response immune responses immunogenic immunogenicity Immunological response Interaction local pain molecular neutralization neutralized Neutralizing antibodies neutralizing antibody Open-label outcome Panel performed phase Phase I phase IIa Primary outcome progressed protocol protocols RBD receive receiving reduction reported Safe Safety SARS-CoV-2 secondary outcome selected Specific T-cell response subjects Subunit vaccine T-cell T-cell Response T-cells Tetanus tetanus toxoid trials Vaccine variant Volunteer volunteers
[DOI] 10.1016/j.vaccine.2022.05.082 PMC 바로가기 [Article Type] Clinical Trial

Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8 + T Cell Response in HLA-A Transgenic Mice

SARS-CoV-2의 엑소좀 백신 로딩 T 세포 에피토프 펩티드는 HLA-A 형질전환 마우스에서 강력한 CD8 + T 세포 반응을 유도합니다

Article

Published on 2022-07-292022-09-11
Journal: International journal of nanomedicine [Category] COVID19(2023년), SARS, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 adjuvant Administered CD8 control group Coronavirus-2 current elicited epitope epitope peptide Ex vivo exosomal vaccine Exosome Exosomes fold followed by fraction frequencies Frequency fused generate HLA-A human leukocyte antigen human leukocyte antigen-A IFN-γ induce injected intracellular cytokine staining leukocyte mice Modification Neutralizing antibodies neutralizing antibody NMR nuclear nuclear magnetic resonance organ toxicity peak peptide peptides purification purified response robust SARS-CoV-2 SARS-CoV-2 virus Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus significantly subcutaneously T cell T cell response T cell responses T cells the SARS-CoV-2 virus the severe acute respiratory syndrome coronavirus-2. transgenic mice transmission electron microscopy Vaccine vaccine group western blotting wild-type
[DOI] 10.2147/IJN.S367494 PMC 바로가기 [Article Type] Article

The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection

KIR2DL2/HLA-C1C1 유전자 쌍은 SARS-CoV-2 감염 위험 증가와 관련이 있습니다

Article

Published on 2022-07-072022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 치료기술,

[키워드] absence antiviral response association blood sample Blood samples causative agent Cell characterized controls COVID-19 COVID-19 infection COVID-19 pathogenesis COVID-19 patient COVID-19 patients dependent on detect DNA early phase frequencies Frequency function healthy controls healthy individuals HLA HLA-C Host in healthy individual incidence of COVID-19 Increased individual Infection Interaction Killer cell KIR KIR2DL2 KIR2DL3 KIR2DS3 Ligand Mild natural killer cell Natural killer cells NK cells no correlation Occurrence Pairing PCR primer protective effect receptor Region risk factor SARS-CoV-2 SARS-COV-2 infection severe disease Signaling significantly higher statistical analysis the healthy virus
[DOI] 10.3389/fimmu.2022.919110 PMC 바로가기 [Article Type] Article

Humoral and cellular immune memory to four COVID-19 vaccines

4가지 COVID-19 백신에 대한 체액 및 세포 면역 기억

Article

Published on 2022-07-072022-09-11
Journal: Cell [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술,

[키워드] Ad26 Ad26.COV2.S antibodies Antibody Response Antibody responses B cell BNT162b2 CD4 CD8 cellular cellular immunity comparable comparison COV2.S COVID-19 COVID-19 case COVID-19 vaccine COVID-19 vaccines CXCR3 deaths Decline detectable examined frequencies Frequency head Human humoral Humoral immunity immune memory immune memory. immune response immune responses immunization individual janssen memory memory B cells memory T Moderna mRNA mRNA vaccine mRNA vaccines mRNA-1273 Multiple Novavax Novavax NVX-CoV2373 NVX-CoV2373 Pathogens Pfizer/BioNTech PROTECT protective immunity representing SARS-CoV2 subject symptomatic T cell T cells vaccination Vaccine vaccinee
[DOI] 10.1016/j.cell.2022.05.022 PMC 바로가기 [Article Type] Article

Knowledge, perception, and fear among the global population towards newly evoked variant Omicron (B.1.1.529)

새로 유발된 변종 오미크론(B.1.1.529)에 대한 세계 인구의 지식, 인식 및 두려움

Article

Published on 2022-07-062022-09-11
Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age Analysis association average average age B.1.1.529 carried Chi-square chi-square test conducted coronavirus COVID-19 cross-sectional deaths Descriptive analysis Fatality rate females frequencies Frequency independent variable Indonesia Infection knowledge knowledge score majority Mean ± standard deviation omicron Omicron variant Patient percentage percentages Perception reported Research responsible SARS-CoV-1 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 SPSS Standard deviation statistical analysis United Kingdom variant was determined was performed
[DOI] 10.1371/journal.pone.0270761 PMC 바로가기 [Article Type] Article